α2‐Antiplasmin and α2‐Macroglobulin—The main inhibitors of fibrinolysis—During the Menstrual Cycle, Pregnancy, Delivery, and Treatment with oral contraceptives
- 11 January 1982
- journal article
- research article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 61 (5) , 417-422
- https://doi.org/10.3109/00016348209156583
Abstract
α2‐Antiplasmin and α2‐macroglobulin have been studied during the menstrual cycle, pregnancy and parturition in healthy women, and during use of various types of contraception in both healthy and diabetic women, and compared with a reference group of healthy men and women.α2‐Antiplasmin showed a slight sex difference, with higher values in women. The luteal phase of the menstrual cycle showed slightly higher values than the other phases. α2‐Antiplasmin increased during pregnancy, decreased (probably due to consumption) during labor and increased again in the puerperium. Treatment with neither combined contraceptive pills nor low dose progestogen pills gave any changes in α2‐antiplasmin.α2‐Macroglobulin showed low values during menstruation. The increase during pregnancy and treatment with combined contraceptive pills is in accordance with earlier findings.It is concluded that synthesis and metabolism of α2‐antiplasmin are under hormonal influence. The role of α2‐antiplasmin in the decreased fibrinolysis in pregnancy is discussed.Keywords
This publication has 16 references indexed in Scilit:
- Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrateScandinavian Journal of Clinical and Laboratory Investigation, 1977
- Identification and Some Properties of a New Fast‐Reacting Plasmin Inhibitor in Human PlasmaEuropean Journal of Biochemistry, 1976
- Coagulation disordersJournal of Clinical Pathology, 1976
- On Fibrinolysis in Diabetes MellitusActa Medica Scandinavica, 1975
- Thrombosis and Oral Contraceptives: Possible PredispositionBMJ, 1973
- Fibrinolytic Activity of Veins in the PuerperiumActa Obstetricia et Gynecologica Scandinavica, 1972
- Studies on Fibrinolytic Inhibitors During PregnancyPublished by Wiley ,1971
- EFFECT OF COMBINED ŒSTROGEN-PROGESTOGEN ORAL CONTRACEPTIVES, ŒSTROGEN, AND PROGESTOGEN ON ANTIPLASMIN AND ANTITHROMBIN ACTIVITYThe Lancet, 1970
- FIBRINOLYSIS IN NEWBORNSActa Paediatrica, 1970
- Fibrinolytic Enzyme System and PregnancyBMJ, 1969